Table 1.
Characteristics of the participants.
| Men | Women without OCT | Women with OCT | |
|---|---|---|---|
| N | 202 | 345 | 76 |
| Age (yr) | 38.4 [25–48.3] | 37.7 [31–42.5] | 30.1 [24–35] |
| BMI (kg/m2) | 27.8 [22.8–28.8] | 28.7 [22.2–32.8] | 25.5 [21.6–27.1] |
| Waist-to-hip ratio | 0.91 [0.85–0.96] | 0.83 [0.79–0.88] | 0.81 [0.75–0.85] |
| Body fat content (%) | 21.4 [16.4–24.6] | 36.7 [28–45.4] | 32.3 [24.3–38.4] |
| Fasting glucose (mmol/l) | 5.1 [4.7–5.4] | 5.2 [4.7–5.4] | 4.7 [4.5–5] |
| Glucose 120 min (mmol/l) | 5.9 [4.5–6.7] | 6.3 [5–7.1] | 6.2 [5-7] |
| OGTT-derived insulin sensitivity index (AU) | 16.6 [8.1–23.7] | 14 [6.8–18.1] | 17.2 [9–21.8] |
| C-peptide 0 min (pmol/l) | 631.5 [447.8–759.3] | 608.1 [397–711.8] | 560.3 [421.8–702.5] |
| C-peptide 30 min (pmol/l) | 2042.3 [1400.5–2430.5] | 1825.8 [1338.5–2150] | 1817.8 [1412–2176.5] |
| Total testosterone (nmol/l) | 17.91 [12.77–22.47] | 1.51 [1.07–1.87] | 1.08 [0.61–1.52] |
Presented are medians [interquartile range]. OCT, oral contraceptive therapy.